Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Doxycycline Carragenate vs Monohydrate
NCT00939562Phase 4Completed
- Sponsor
- Pfizer
- Start
- Nov 2008
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of doxycycline in bacterial infection (2 arms), sponsored by Pfizer. Primary endpoints: Maximum Plasma Concentration of Doxycycline and Area Under Plasma Concentration-Time Profile From Time Zero to Infinity. Started Nov 2008; status: completed.
02
Drugs
doxycycline
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT00939562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00939562.